Skip to main content
. 2019 Feb 18;24(4):735. doi: 10.3390/molecules24040735

Figure 4.

Figure 4

Effects of systemically (i.v.) administered ghrelin antagonist on the plasma oxytocin level (expressed as pg/mL). Results shown as means ± S.E.M., n = 10. Statistical significance: * p < 0.05 relative to the control group and # p < 0.05 relative to the 10 pmol ghrelin-treated group.